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Purpose. Bladder cancer is a frequent cause of haematuria in elderly patients, and bladder ultrasound (US) is a valuable tool
in diagnosing these malignancies. We examined the accuracy of 3D bladder US in diagnosing bladder tumors in patients with
haematuria.PatientsandMethods.Twenty-onepatientsobservedintheemergencydepartmentforhaematuriaunderwentakidney
and bladder US. Patients with normal or uncertain bladder US ﬁndings underwent a 3D US and a cystoscopy. Results. In 5 (23.8%)
patients, the 3D US detected bladder tumours not seen in 2D US. All these patients were found to have bladder tumours on
cystoscopy. Another 5 (23.8%) patients with uncertain ﬁndings on 2D US had normal 3D US and cystoscopy. 3D US showed a
sensitivity of 83.3% and a speciﬁcity of 100% with a positive predicted value and negative predictive values of 100% and 93.8%,
respectively. Conclusion. 3D US was more sensitive than 2D US in diagnosing bladder tumours in patients with haematuria.
1.Introduction
Gross haematuria can be a very distressing and frightening
symptom and usually leads patients to seek immediate
medical care. The cause of haematuria should be thoroughly
evaluated and in adults should be regarded as a sign of
malignancy until proven otherwise. Ultrasound (US) is one
of the initial examinations performed and is very useful in
detecting kidney and bladder lesions.
The sensitivity of US in detecting bladder tumours
(BT) is variably reported to range from 26% to over 80%
[1, 2]. However, this rate is much lower in patients with
tumours smaller than 5mm or for tumours located on the
bladder dome or anterior wall [2]. Similarly, speciﬁcity is
decreased in the presence of coexisting focal cystitis, bladder
trabeculations, and haematuria with clots. For this reason, a
signiﬁcantnumberofbladderUSarenormalorinconclusive,
and cystoscopy is necessary to discard the presence of a
bladder tumour [3].
Three-dimension US imaging has recently become a
widely available feature in many ultrasound machines. This
technology permits the acquisition and storage of a dataset,
selected from a speciﬁc region of interest. This dataset can
be further analysed, either by multiplanar display, surface
rendering, or volume calculation. As there is a considerable
contrast gradient between the bladder lumen and its wall,
the surface rendering algorithm can usually display with
suﬃcient detail the surface of the bladder, revealing a
cystoscopic-like image, enhancing the characterization of
bladder wall abnormalities [4].
In this study, we examined the value of 3D US in diag-
nosing bladder tumours in patients with haematuria of un-
known cause.
2. Patients andMethods
Patients admitted in the emergency department present-
ing with painless gross haematuria and without history
of trauma or evidence of urinary tract infection were
prospectively enrolled. All patients underwent conventional
2D bladder and kidney US in the emergency department
performed by a radiologist. When needed, bladder clot
evacuation was performed previous to the US. Examining
physicians were asked to report the bladder US as “with
BT” or “no BT.” In some patients, the radiologist observed2 ISRN Urology
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Figure 1: Results of 2D US, 3D US, cystoscopy, and pathology examination.
bladder lesions that were more diﬃcult to characterize,
because of unclear limits or image artefacts. These cases
were reported as “uncertain.” Patients diagnosed with kidney
disease, bladder tumours, or calculi causing the haematuria
were excluded. Patients with “no BT” or “uncertain” bladder
USﬁndingswerescheduledfora3DUSexamination,usually
the next day, followed by ﬂexible or rigid cystoscopy.
A Philips HDI 4000 ultrasound system (Philips Medical
Systems, Best; Netherlands) with a 3.5–5MHz transabdomi-
nal probe was used. A single urologist performed the 3D US
examination. Patients were asked to drink about 1L of water
and not to void 1h before the study in order to perform it
with near maximum bladder capacity (volume ≥ 250cc), a
2D US was carried out in the sagital and transverse plane,
and afterwards several 3D acquisitions (2 to 5 datasets, mean
2,5) were made and evaluated using the surface rendering
algorithm.
Comparative analysis was carried out between the
imaging ﬁndings collected by 2D and 3D US to those of
the cystoscopy. Cochrane’s Q test was used to determine
statistical diﬀerences.
3. Results
Twenty one patients (19 men and 2 women, mean age 69.0
years old) were enrolled in the study. Twelve (57%) where
reported as “no BT” and 9 (43%) as “uncertain” on the con-
ventional 2D US performed in the emergency department.
The 3D examination found “no BT” in 15 patients
(71.4%). In 5 of these patients, the 2D US was “uncertain,”
largely because they had bladder trabeculation that made
the 2D US diﬃcult to interpret. None of these patients had
bladder tumour on cystoscopy (Figure 1).
In 5 (23.8%) patients, 3D US identiﬁed bladder tumours
that were not detected in the previous US examination.
This was statistically diﬀerent from the results of 2D US
(P = 0,025). All these patients were found to have bladder
tumours on cystoscopy, although in one patient cystoscopy
revealed another 5mm lesion that was not detected on US.
In one patient the 3D US was inconclusive, but followup
cystoscopy revealed a bladder tumour.
All 6 patients with bladder tumours on cystoscopy
underwent a transurethral resection; 4 had transitional cell
carcinomas (TCCs), 1 had a papilloma, and the remaining
patient was revealed to have only inﬂammation. Lesion
diameter ranged from 5 to 20mm (mean 7mm).
In the population with negative 2D US, the 3D US
showed a sensitivity of 83,3% and a speciﬁcity of 100% in
identifying patients with BT, with a positive predictive
value and negative predictive values of 100% and 93,8%,
respectively.
4. Discussion
When evaluating patients with painless haematuria, it is
mandatorytoexcludetheexistenceoftumoursoftheurinary
tract. US imaging is one of the frontline examinations since
it is widely available and noninvasive. When a US clearly
shows a bladder tumour, a transurethral resection is usually
subsequentlyperformed;however,whentheUSexamination
is normal or ambiguous, a diagnostic cystoscopy becomes
mandatory. Flexible cystoscopy, though less traumatic, is still
an invasive procedure associated with patient discomfort
and can by itself be the cause of urinary tract infections
and haematuria. In order to overcome these problems, other
imaging techniques such as contrast enhanced US [8, 9], and
virtual cystoscopy performed with computed tomography
or magnetic resonance imaging, have been developed with
promisingresults[10–13].Thesetechniquesseemtobemore
sensitive than US but signiﬁcantly more time consuming,
expensive, and frequently inaccessible for clinicians. More-
over, all these imaging techniques are unable to detect subtleISRN Urology 3
Figure 2: (a) View of a trabeculated bladder and prostatic median lobe in 2D and 3D US. (b) View of a small bladder tumour (papilloma)
in 3D US and cystoscopy. (c) 2D and 3D view of a bladder dome tumour in a patient with an indwelling catheter.
alterations of bladder mucosa such as carcinoma in situ [13].
For such lesions, cystoscopy and, more recently, ﬂuorescence
cystoscopy and narrow-band imaging cystoscopy are still the
most accurate examinations [14, 15].
Three-dimensional ultrasound is now an established
imaging tool in several specialities, this technology is
available in most medium and upscale equipments and is
routinely used in obstetric US. In urology, it has been used
in planning and guiding prostate cancer treatments [16], to
accurately measure bladder volume [17] and in imaging the
urethral sphincter in pelvic ﬂoor disorders [18]. Recently,
the use of 3D US in the evaluation of bladder tumours has
been reported showing a moderate-to-perfect interobserver
agreement [6]. Wagner et al. [19] studied 3D US as a staging
tool in distinguishing invasive from noninvasive bladder
tumours, showing an overall accuracy of 79%. This technol-
ogy has also been studied as a screening tool; Mitterberger
et al. [5] studied 42 patients with painless haematuria, all
of whom had an abnormal 2D US. They found that 3D US
diagnosis was correct in 86% of patients whereas 2D US
diagnosis was correct only in half of them. Another group
[7] compared the accuracy of 2D and 3D US in 14 patients
withprovenBTandfound3DUStohavebettersensitivity.In
our study, we evaluated only patients with an undetermined
cause of haematuria after 2D US, and we similarly found
greater sensitivity of 3D US in detecting bladder tumours
(Table 1). However, this sensitivity was not related to lesion
size since 57% of lesions were 10mm or more. This might be
explainedbythefactthatthe3Dreconstructionfacilitatesthe
distinction of tumour lesions from bladder folds, becoming
particularly useful in patients with bladder trabeculations
and diverticula. Although cystoscopy is still mandatory in
those patients with an unidentiﬁed cause of haematuria, we
thinkthat3DUScanavoidcystoscopiesbyclearlyidentifying
and accurately characterizing bladder lesions. In this series,
5 patients (23.8%) could have skipped cystoscopy and be
directly referred for a transurethral resection, saving patient
discomfort, time, and money.
Although not prospectively assessed in this study, the
speciﬁcity of 3D US seems to be superior to 2D US. In4 ISRN Urology
Table 1: Overview of published studies on 3D bladder ultrasound
in the diagnosis of bladder tumours.
Reference Number of
patients
Number of tumour lesions detected
2D 3D Cystoscopy
Mitterberger et
al. [5] 42 29 37 37
Kocakoc et al.
[6] 28 39 41 47
Park et al. [7]1 4 1 9 2 2 2 8
Current study 21 0 5 7
Total 105 87 105 119
Sensitivity∗ (%) 73,1 88,2 100
∗Calculations were made considering cystoscopy as the “gold standard”.
our series, in 5 patients which had uncertain ﬁndings on
2D US, the subsequent 3D reconstruction has shown better
characterizationoftheirlesionsandclearlyidentiﬁedbladder
trabeculae and prostatic median lobe that could mimic a BT
on2DUS.Furtherinvestigationisnecessarytodeterminethe
actual improvement in speciﬁcity of 3D US in these patients.
We are aware that in this study 2D and 3D US were
performed under diﬀerent conditions: the ﬁrst was done
in the emergency department by a radiologist, and the
second in a diﬀerent day by a urologist. The degree of
haematuria may also have been diﬀerent between the two
examinations, however, clot removal was performed before
the US whenever necessary, so the degree of haematuria
should not have a major impact on the exam performance.
Bladder 3D US is simple to perform and interpret.
We usually carry out 2 to 3 volume acquisitions with a
mechanicalmotor-driventransducerandevaluatetheimages
using a surface-rendering algorithm. The images generated
areclearlyidentiﬁedasthebladderlumen(Figure 2).Bladder
tumours appear as round or oval protrusions into the
bladder lumen and most software allows navigation through
the surface of the bladder, and looking at the lesions from
diﬀerent angles. Overall, this procedure may add as little as
5 to 10 minutes to the examination time but substantially
improves the overall accuracy of the exam, therefore, we
think that this technology when available should be used
in the diagnostic workup of patients with haematuria of
unknown cause.
5. Conclusion
Three-dimensional bladder US has superior sensitivity than
2D US in diagnosing bladder tumours in patients with
haematuria. Although cystoscopy is still the gold standard
examination, 3D US is a promising tool in diagnosing blad-
der tumours and might reduce the number of cystoscopies
needed to study these patients.
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